Active Ingredient: BRINZOLAMIDE
Proprietary Name: BRINZOLAMIDE
Dosage Form; Route of Administration: SUSPENSION/DROPS; OPHTHALMIC
Strength: 1%
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A211914
Product Number: 001
Approval Date: Jul 28, 2023
Applicant Holder Full Name: PADAGIS US LLC
Marketing Status:
Prescription
Patent and Exclusivity Information
